| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-08 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-08 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-07 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-06 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |